Klier C M, Roble A G, Kolenbrander P E
Oral Infection and Immunity Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892-4350, USA.
Oral Microbiol Immunol. 1998 Dec;13(6):337-40. doi: 10.1111/j.1399-302x.1998.tb00688.x.
Actinomyces serovar WVA963 strain PK1259 mediates intergeneric coaggregation with several oral streptococci. These lactose-inhibitable coaggregations appear to involve a 95-kDa putative actinomyces adhesin in complex with type 2 fimbriae. A coaggregation-defective strain PK2407 lacking type 2 fimbriae synthesizes the putative adhesin but appears unable to present it properly on its surface. Antiserum was raised against surface sonicates of PK2407 and was absorbed with a different coaggregation-defective mutant PK3092 that synthesizes type 2 fimbriae but no adhesin. This absorbed antiserum specifically blocked lactose-inhibitable coaggregation of wild-type strain PK1259 and Streptococcus oralis 34 and identified a 95-kDa protein in ammonium sulfate precipitates of culture supernatant of the coaggregation-defective mutant PK2407. The 95-kDa secreted protein was bound to the streptococcal partner cells and to lactose-agarose affinity beads and was released by lactose from both the affinity beads and partner, indicating that the secreted and precipitated protein is biochemically active and may mediate coaggregation with streptococci.
放线菌血清型WVA963菌株PK1259可介导与多种口腔链球菌的属间共聚。这些乳糖抑制性共聚似乎涉及一种95 kDa的假定放线菌粘附素与2型菌毛形成复合物。缺乏2型菌毛的共聚缺陷菌株PK2407能合成假定粘附素,但似乎无法将其正确呈现在其表面。用PK2407的表面超声裂解物制备抗血清,并用另一种共聚缺陷突变体PK3092吸收,PK3092能合成2型菌毛但不合成粘附素。这种吸收后的抗血清特异性地阻断了野生型菌株PK1259和口腔链球菌34的乳糖抑制性共聚,并在共聚缺陷突变体PK2407培养上清液的硫酸铵沉淀中鉴定出一种95 kDa的蛋白质。这种95 kDa的分泌蛋白与链球菌伙伴细胞和乳糖 - 琼脂糖亲和珠结合,并可被乳糖从亲和珠和伙伴细胞中释放出来,表明分泌和沉淀的蛋白具有生化活性,可能介导与链球菌的共聚。